1159826-74-0

Basic information

• Product Name: N-BOC-8-AZABICYCLO[3.2.1]OCTANE-3-CARBOXYLIC ACID
• Synonyms: 8-(tert-Butoxycarbonyl)-8-azabicyclo[3.2.1]octane-3-carboxylic acid;-8-azabicyclo[3.2.1]octane-3-carboxylic acid
• CAS NO: 1159826-74-0
• Molecular Formula: C13H21NO4
• Molecular Weight: 255.31014
• Mol File: 1159826-74-0.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 386.0±35.0 °C(Predicted)
• Appearance: /
• Density: 1.196±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 4.54±0.20(Predicted)
• CAS DataBase Reference: N-BOC-8-AZABICYCLO[3.2.1]OCTANE-3-CARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: N-BOC-8-AZABICYCLO[3.2.1]OCTANE-3-CARBOXYLIC ACID(1159826-74-0)
• EPA Substance Registry System: N-BOC-8-AZABICYCLO[3.2.1]OCTANE-3-CARBOXYLIC ACID(1159826-74-0)

Safety Data

• Hazardous Substances Data: 1159826-74-0(Hazardous Substances Data)

Usage

General Description

N-Boc-8-Azabicyclo[3.2.1]octane-3-carboxylic acid is a compound with the chemical formula C14H23NO4. It is a derivative of 8-azabicyclo[3.2.1]octane, a bicyclic compound with nitrogen in the ring structure. The compound contains a Boc (tert-butoxycarbonyl) protecting group attached to the nitrogen atom and a carboxylic acid functional group. It is commonly used as a building block in organic synthesis, particularly in the field of pharmaceuticals. The compound has diverse applications and can be used as a starting material in the synthesis of various drugs and biologically active compounds.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 690952-61-5 methyl 8-azabicyclo[3.2.1 ]octane-3-carboxylate 
• 856900-26-0 3-cyano-8-azabicyclo[3.2.1]octane-8-carboxylic acid tert-butyl ester 
• 185099-67-6 Boc-tropinone 
• 1204809-89-1 8-(tert-butoxycarbonyl)-8-azabicyclo[3.2.1]oct-3-ene-3-carboxylic acid 
• 185099-68-7 tert‐butyl 3‐(trifluoromethanesulfonyloxy)‐8‐azabicyclo[3.2.1]oct‐2‐ene‐8‐carboxylate 

Downstream Products

• 799283-62-8 tert-butyl 3-(hydroxymethyl)-8-azabicyclo[3.2.1]octane-8-carboxylate 
• 185099-67-6 N-Boc-nortropinone 
• 1548548-51-1 (1R,3S,5S)-8-tert-butyl 3-methyl 8-azabicyclo[3.2.1]octane-3,8-dicarboxylate 
• 1548292-34-7 (1R,3R,5S)-8-tert-butyl 3-methyl 8-azabicyclo[3.2.1]octane-3,8-dicarboxylate 
• 1548292-06-3 (1R,3S,5S)-8-tert-butyl 3-methyl 3-(2-aminoethyl)-8-azabicyclo[3.2.1]octane-3,8-dicarboxylate 
• 1548548-59-9 (1R,3R,5S)-8-tert-butyl 3-methyl 3-(2-aminoethyl)-8-azabicyclo[3.2.1]octane-3.8-dicarboxylate 

Relevant articles and documents

ARYLMETHYLENE HETEROCYCLIC COMPOUNDS AS KV1.3 POTASSIUM SHAKER CHANNEL BLOCKERS

A compound of Formula (I) or a pharmaceutically acceptable salt thereof is described, wherein the substituents are as defined herein. Pharmaceutical compositions comprising the same and method of using the same are also described.

ANALOGUES OF 4H-PYRAZOLO[1,5-a] BENZIMIDAZOLE COMPOUND AS PARP INHIBITORS

Disclosed is a series of analogues of 4H-pyrazolo[1,5-α]benzimidazole compound as PARP inhibitors. In particular, disclosed in the invention is a compound as shown by formula (I) or a pharmaceutically acceptable salt thereof as a PARP inhibitor.

BICYCLIC HETEROCYCLE DERIVATIVES AND METHODS OF USE THEREOF

The present invention relates to Bicyclic Heterocycle Derivatives, compositions comprising a Bicyclic Heterocycle Derivative, and methods of using the Bicyclic Heterocycle Derivatives for treating or preventing obesity, diabetes, a metabolic disorder, a cardiovascular disease or a disorder related to the activity of a GPCR in a patient.